Trial Profile
Phase III Randomized Placebo-controlled Double Blind Comparative Study to Investigate the Efficacy and Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without Intubation Under Monitored Sedation Care
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Registrational; Therapeutic Use
- Sponsors Hospira
- 23 Jul 2015 Endpoints; Patient inclusion and exclusion criteria been amended.
- 30 Mar 2014 New trial record